Skip to main content
. 2014 Aug 17;2014:123079. doi: 10.1155/2014/123079

Figure 1.

Figure 1

(a) OS of the 24 AML patients according to PB-WT1 level before allo-SCT. (b) LFS of the 24 AML patients according to PB-WT1 level before allo-SCT.